PlainRecalls
FDA Drug Moderate Class II Ongoing

Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-169-15

Reported: June 18, 2025 Initiated: May 13, 2025 #D-0460-2025

Product Description

Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-169-15

Reason for Recall

Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules

Details

Recalling Firm
AvKARE
Units Affected
3,817 50-count cartons
Distribution
Nationwide in the USA
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-169-15. Recalled by AvKARE. Units affected: 3,817 50-count cartons.
Why was this product recalled?
Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules
Which agency issued this recall?
This recall was issued by the FDA Drug on June 18, 2025. Severity: Moderate. Recall number: D-0460-2025.